TP
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Rifampicin in staphylococcal implant infections : Precision use or pitfall ? | CMI communications | 2025 | 13 | 55 | |||
| Identification of causative agents of infective endocarditis by metagenomic next-generation sequencing of resected valves | Frontiers in cellular and infection microbiology | 2025 | 12 | 12 | |||
| First report of uncommon mycobacteria in post LASIK keratitis: Mycobacterium wolinskyi | Journal of ophthalmic inflammation and infection | 2024 | 47 | 174 | |||
| Daptomycin Exposure as a Risk Factor for Daptomycin-Induced Eosinophilic Pneumonia and Muscular Toxicity | Clinical infectious diseases | 2023 | 117 | 0 | |||
| Actualités thérapeutiques en orthopédie septique | Revue médicale suisse | 2023 | 70 | 110 | |||
| SPILF update on bacterial arthritis in adults and children | Infectious diseases now | 2023 | 107 | 0 | |||
| Infections ostéo-articulaires chez les patients transplantés d'organes solides | 2023 | 481 | 494 | ||||
| Le pied diabétique infecté | Revue médicale suisse | 2022 | 208 | 414 | |||
| Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-debridement Antibiotic Treatment for 10 versus 20 days | Annals of surgery | 2022 | 262 | 403 | |||
| Prothèse totale de genou et lésion des tissus mous : quelles options pour la reconstruction ? | Revue médicale suisse | 2022 | 248 | 389 | |||
| Seventeen Cases of Daptomycin-Induced Eosinophilic Pneumonia in a Cohort of Patients Treated for Bone and Joint Infections: Proposal for a New Algorithm | Open forum infectious diseases | 2022 | 121 | 171 | |||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 245 | 143 | |||
| Maladies infectieuses | Revue médicale suisse | 2021 | 392 | 116 | |||
| Cost of off-label antibiotic therapy for bone and joint infections: a 6-year prospective monocentric observational cohort study in a referral centre for management of complex osteo-articular infections | Journal of bone and joint infection | 2021 | 175 | 153 | |||
| Is routine measurement of the serum C-reactive protein level helpful during antibiotic therapy for diabetic foot infection? | Diabetes, Obesity and Metabolism | 2021 | 193 | 0 | |||
| Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study | Open forum infectious diseases | 2021 | 185 | 204 | |||
| A systematic review of phage therapy applied to bone and joint infections: an analysis of success rates, treatment modalities and safety | EFORT open reviews | 2021 | 260 | 403 | |||
| Second Periprosthetic Joint Infection Caused by Streptococcus dysgalactiae: How Genomic Sequencing Can Help Defining the Best Therapeutic Strategy | Frontiers in Medicine | 2020 | 393 | 182 | |||
| Rubor, calor, dolor, tumor: infections de la peau et des tissus mous | Revue médicale suisse | 2020 | 844 | 260 | |||
| Ulcère du pied chez un patient avec un diabète : quelle prise en charge médico-chirurgicale ? | Revue médicale suisse | 2020 | 340 | 1 | |||
| Performances and usefulness of Xpert MTB/RIF assay in low-incidence settings: not that bad? | European Journal of Clinical Microbiology & Infectious Diseases | 2020 | 227 | 0 | |||
| Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: A prospective, randomized, non-inferiority pilot trial | Clinical Infectious Diseases | 2020 | 347 | 1,091 | |||
| Morsures animales et humaines : que faire et à quoi penser ? | Revue médicale suisse | 2019 | 612 | 3 | |||
| Prise en charge des infections sur prothèses : quoi de neuf ? | Revue médicale suisse | 2018 | 449 | 202 | |||
| Disseminated emboli caused by a large vegetation in staphylococcus aureus endocarditis | American Journal of Clinical Microbiology and Antimicrobials | 2018 | 467 | 108 | |||
| Anticoagulants de type antivitamines K : effets délétères potentiels chez les patients avec une IRC | Revue médicale suisse | 2012 | 253 | 242 |
